The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase III open-label study of nivolumab (anti-PD-1; BMS-936558; ONO-4538) versus investigator’s choice in advanced melanoma patients progressing post anti-CTLA-4 therapy.
Bartosz Chmielowski
Consultant or Advisory Role - Bristol-Myers Squibb
Honoraria - Bristol-Myers Squibb
Omid Hamid
Consultant or Advisory Role - Genentech
Honoraria - Genentech
Research Funding - Genentech
David R. Minor
Consultant or Advisory Role - Bristol-Myers Squibb
Honoraria - Bristol-Myers Squibb
Sandra P. D'Angelo
No relevant relationships to disclose
Gregory K. Pennock
Honoraria - Bristol-Myers Squibb
Kenneth Grossmann
Consultant or Advisory Role - Bristol-Myers Squibb
Honoraria - Bristol-Myers Squibb
Paolo Antonio Ascierto
Consultant or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; MedImmune; MSD; Novartis; Roche/Genentech
Honoraria - Bristol-Myers Squibb; MSD; Roche/Genentech
Adil Daud
No relevant relationships to disclose
Reinhard Dummer
Consultant or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Cephalon; Genta; GlaxoSmithKline; MSD; Novartis; Roche; Spirig Pharma AG; Transgene
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Cephalon; Genta; GlaxoSmithKline; MSD; Novartis; Roche; Spirig Pharma AG; Transgene
Research Funding - AstraZeneca; Bayer; Bristol-Myers Squibb; Cephalon; GlaxoSmithKline; MSD; Novartis; Roche; Transgene
F. Stephen Hodi
Consultant or Advisory Role - Bristol-Myers Squibb (U)
Céleste Lebbé
Consultant or Advisory Role - Roche
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Roche
Expert Testimony - Roche (U)
Caroline Robert
Consultant or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Roche
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Roche
Jeffrey Alan Sosman
Consultant or Advisory Role - Genentech
Honoraria - Millennium; Roche
Research Funding - Bristol-Myers Squibb
Arvin Yang
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Alexandre Lambert
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Jeffrey S. Weber
Consultant or Advisory Role - Bristol-Myers Squibb
Honoraria - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb